Related Experiment Video
Updated: Jun 3, 2026
Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
Published on: February 3, 2021
Effect of NT-proBNP testing on diagnostic certainty in patients admitted to the emergency department with possible
Daniel Robaei1, Lisa Koe, Renze Bais
1Department of Cardiology, Royal North Shore Hospital, St Leonards, NSW 2065, Australia.
Insights
Measuring amino-terminal pro-B-type natriuretic peptide (NT-proBNP) significantly reduces diagnostic uncertainty for emergency department physicians evaluating patients with suspected heart failure (HF). This biomarker improves diagnostic accuracy, leading to more timely and appropriate treatment for dyspnoea.
Area of Science:
- Cardiology
- Emergency Medicine
- Biomarker Research
Background:
- Distinguishing heart failure (HF) from other causes of dyspnoea in the emergency department (ED) is challenging, potentially delaying treatment.
- While the diagnostic utility of serum amino-terminal pro-B-type natriuretic peptide (NT-proBNP) is known, its impact on physician diagnostic certainty in the ED is less studied.
Purpose of the Study:
- To determine if providing NT-proBNP results to ED physicians improves their diagnostic certainty for patients presenting with suspected HF.
Main Methods:
- A randomized controlled study involving 68 patients presenting to the ED with dyspnoea.
- ED clinicians initially assessed HF probability (1-7 scale) without NT-proBNP results.
- Physicians reassessed HF probability after receiving NT-proBNP results in 38 patients.
Main Results:
- Providing NT-proBNP results decreased diagnostic uncertainty (score 3-5) from 66% to 18% (P < 0.0001).
- Diagnostic accuracy improved from 53% to 71% (P = 0.016) with NT-proBNP results.
Conclusions:
- Measuring NT-proBNP concentrations effectively reduces diagnostic uncertainty in ED patients with suspected HF.
- NT-proBNP testing improves diagnostic accuracy, aiding in the management of dyspnoea in the ED.
Background:
Difficulty in distinguishing congestive heart failure (HF) from other causes of dyspnoea in the emergency department (ED) may result in delay in appropriate treatment and referral. Although the diagnostic value of serum amino-terminal pro-B-type natriuretic peptide (NT-proBNP) is well documented, the impact on diagnostic certainty of providing these results to ED physicians is not well studied. We sought to determine the effect of providing NT-proBNP results on diagnostic certainty of physicians managing patients presenting to the ED with suspected HF.
Methods:
A randomized controlled study was conducted in 68 patients presenting to the ED with dyspnoea. ED clinicians initially rated the probability of HF as the cause of dyspnoea without the knowledge of the result. A scale of 1-7 was used, with 1 representing a high degree of certainty of a diagnosis other than HF and 7 representing a high degree of certainty of HF being the cause of dyspnoea. In 38 patients, the ED physician then reassessed the probability of HF as the cause of dyspnoea after receiving the NT-proBNP result. A cardiologist blinded to the NT-proBNP result determined the final diagnosis after review of medical records and investigations.
Results:
Providing the NT-proBNP result reduced diagnostic uncertainty, defined as a test score of 3-5, from 66% of cases to 18% of cases (P < 0.0001) and improved diagnostic accuracy from 53% to 71% (P = 0.016).
Conclusion:
Measurement of NT-proBNP concentrations reduces diagnostic uncertainty and improves diagnostic accuracy in patients presenting to the ED with dyspnoea and possible HF.
Related Concept Videos
01:30Acute Coronary Syndrome III: Diagnostic Studies
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:13Sensitivity, Specificity, and Predicted Value
Sensitivity is the...
01:26Exercise Stress Test
Exercise stress testing, commonly known as a treadmill test, is a noninvasive procedure used to evaluate cardiovascular function and diagnose heart conditions.
Definition
An exercise stress test measures the heart's response to exertion using a treadmill or stationary bicycle. Chest electrodes record the heart's electrical activity through an ECG, and blood pressure is monitored regularly.
Purposes
01:30Heart Failure VII: Nursing Interventions
01:30Heart Failure IV: Classification and Diagnostic Evaluation